首页|广州地区利奈唑胺耐药结核分枝杆菌耐药基因特征分析

广州地区利奈唑胺耐药结核分枝杆菌耐药基因特征分析

扫码查看
目的 分析广州地区利奈唑胺(linezolid,LZD)耐药结核分枝杆菌临床分离株耐药基因的突变特征,为控制广州地区耐利奈唑胺结核病提供一定的研究基础和依据。方法 选取 2012 年 1 月~2022 年 1 月广州市胸科医院住院患者的 60 株利奈唑胺耐药结核分枝杆菌的临床分离株,分为耐多药组和广泛耐药组。采用微孔板稀释法对 60 株菌株进行利奈唑胺最低抑菌浓度(MIC)检测,并对 60 株菌株的利奈唑胺耐药基因 23S rRNA、rplC、rplD进行测序,分析其突变特征。结果 60 株LZD耐药株对LZD的MIC值分布于 2~32 μg/ml之间。耐多药组的MIC50 和MIC90 分别为 2 μg/ml、32 μg/ml,广泛耐药组的MIC50 和MIC90 分别为 8 μg/ml、32 μg/ml。60 株菌株中发现有 12 株 23S rRNA基因发生突变,其中有 1 株发生两个基因位点突变;有 11 株rplC基因发生突变,其中有 1 株发生双位点突变;发现 2 株rplD基因发生突变。23S rRNA、rplC基因突变发生率在不同性别和年龄患者中差异无统计学意义(P>0。05)。结论 广州地区利奈唑胺耐药结核分枝杆菌耐药基因 23S rRNA、rplC突变发生率明显高于rplD,在不同性别和不同年龄患者中的发生率无显著差异。
Analysis of drug resistantance gene characteristics of linezolid resistance in mycobacterium tuberculosis in Guangzhou
Objective To analyze the mutation characteristics of linezolid(LZD)resistance gene in drug-resistant mycobacterium tuberculosis isolates in Guangzhou,and to provide a foundation for controlling linezolidin-resistant tuberculosis.Methods Sixty strains of LZD-resistant mycobac-terium tuberculosis isolated from hospitalized patients in Guangzhou Chest Hospital from January 2012 to January 2022 and divided into multi-drug resistance group and pan-drug resistance group.The MICs of linezolidin of the 60 strains were determined by microplate dilution method.The genes,related to LZD resistance,of 23S rRNA,rplC and rplD of 60 strains were sequenced and their mutation characteristics were analyzed.Results The MIC values of the 60 strains against LZD ranged from 2 μg/ml to 32 μg/ml.The MIC50 and MIC90 in multi-drug resistance group were 2 μg/ml and 32 μg/ml,respectively,while those in pan-drug resistance group were 8 μg/ml and 32 μg/ml,respectively.Among the 60 strains,12 strains had mutations in the 23S rRNA gene,and 1 strain had two mutations.There were 11 strains of rplC gene mutation,of which 1 strain had double-site mutation.Two isolates had mutations in rplD gene.There were no significant difference in mutation rates of 23S rRNA and rplC gene among different genders and ages(P>0.05).Conclusion The mutation rates of 23S rRNA and rplC genes in drug-resistant mycobacterium tuberculosis are significantly higher than rplD gene in Guangzhou,but there is no significant difference in mutation rate among different genders and ages.

Mycobacterium tuberculosisLinezolidDrug resistance gene

李雪雅、许蕴怡、胡族琼、刘志辉

展开 >

广州市胸科医院检验科,广州 510095

结核分枝杆菌 利奈唑胺 耐药基因

广州市卫生健康科技项目广州市科技计划

20221A0110452023A03J0539

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(5)
  • 18